Anand Desai, managing director of Anupam Rasayan said, “This molecule is an advanced intermediate to be used as a key building block for manufacturing high-end engineering fluids and also in active pharmaceutical ingredient, this product development further demonstrates our prowess in developing and manufacturing complex fluorinated products.”

"This is a major step towards expanding our geographic presence in the US. With this LOI, we expect our share of revenues from the US to increase significantly in the coming years. This product is being manufactured for the first time in India and aligns well with the Government of India's Make in India campaign.”

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.

The company's consolidated net profit rose 13.2% to Rs 42.91 crore on 43.8% jump in revenue from operations to Rs 382.75 crore in Q3 FY23 over Q3 FY22.